Company / Operating Cash Flow per Share
Q32 Bio Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$5.55
FY2025
5-year range
-$51.94 / -$1.88
FY2021-FY2025
Trend
+89.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $-5.55.
Based on SEC 10-K filings.
-5.55 in FY2025.
Declined from $-1.98 to $-5.55 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 89.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.55 | +89.3% |
| FY2024 | -$51.94 | -2527.0% |
| FY2023 | -$1.98 | -3.0% |
| FY2022 | -$1.92 | -2.3% |
| FY2021 | -$1.88 | +7.3% |
| FY2020 | -$2.02 | -77.7% |
| FY2019 | -$1.14 | -146.4% |
| FY2018 | $2.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026